Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Neelesh R. Soman"'
Autor:
Priyanka D Joshi PhD, Stowe Shoemaker PhD, Corrin C Sullivan MEd, PhD, Neelesh R Soman MD, PhD
Publikováno v:
Journal of Patient Experience, Vol 7 (2020)
We present here a syllabus for teaching patient experience that draws on service sciences to address the current state of patient experience. The syllabus was the result of an ongoing collaboration between educators at the Hotel College and the Schoo
Externí odkaz:
https://doaj.org/article/90f6af2e877748ed8b6d343159c8d132
Publikováno v:
Journal of Patient Experience, Vol 7 (2020)
Journal of Patient Experience
Journal of Patient Experience
We present here a syllabus for teaching patient experience that draws on service sciences to address the current state of patient experience. The syllabus was the result of an ongoing collaboration between educators at the Hotel College and the Schoo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f5e12f248f0200aaa6214fcf7ede921
https://doi.org/10.1177/2374373519870008
https://doi.org/10.1177/2374373519870008
Autor:
Jacob W. Myerson, Joshua L. Hood, Jon N. Marsh, Gregory M. Lanza, Paul H. Schlesinger, Hua Pan, Samuel A. Wickline, Olena Ivashyna, Neelesh R. Soman
Publikováno v:
The FASEB Journal. 24:2928-2937
Current strategies for deploying synthetic nanocarriers involve the creation of agents that incorporate targeting ligands, imaging agents, and/or therapeutic drugs into particles as an integral part of the formulation process. Here we report the deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd098f494a2ab420f049d435dcb8cbd
https://doi.org/10.1096/fj.09-153130
https://doi.org/10.1096/fj.09-153130
Publikováno v:
Nano Letters. 8:1131-1136
The therapeutic potential of cytolytic peptides is plagued by nonspecificity and enzymatic degradation. We report the first stable incorporation of melittin (a 26 amino acid amphipathic peptide) into an outer lipid monolayer of perfluorocarbon nanopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433e809ecf6ed29952a94dbd497d4fcb
https://doi.org/10.1021/nl073290r
https://doi.org/10.1021/nl073290r
Publikováno v:
IEEE Transactions on Nanobioscience. 5:69-75
Perfluorocarbon nanoparticles consisting essentially of liquid perfluoro-octyl bromide (PFOB) core surrounded by a lipid monolayer can serve as highly specific site-targeted contrast and therapeutic agents after binding to cellular biomarkers. Based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da058dbd2ac016dbaa7d1287aff497f
https://doi.org/10.1109/tnb.2006.875052
https://doi.org/10.1109/tnb.2006.875052
Autor:
Neelesh R. Soman, Paul H. Schlesinger, Jon N. Marsh, Hua Pan, Gregory M. Lanza, Eric T. Christenson, Samuel A. Wickline, Olena Ivashyna
Publikováno v:
Methods in enzymology. 508
Cytolytic peptides have commanded attention for their anticancer potential because the membrane-disrupting function that produces cell death is less likely to be overcome by resistant mutations. Congruently, peptides that are involved in molecular re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538107ba5891710059ddc97866f3e30d
https://pubmed.ncbi.nlm.nih.gov/22449919
https://pubmed.ncbi.nlm.nih.gov/22449919
Publikováno v:
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. 3(3)
Cytolytic peptides are an attractive class of anticancer candidates because of their wide-spectrum lytic properties. However, their therapeutic potential cannot be realized without a proper delivery vehicle, because of their off-target toxicity, nons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7c5956d30cb27b2bdf0c0ed259d11f
https://pubmed.ncbi.nlm.nih.gov/21225660
https://pubmed.ncbi.nlm.nih.gov/21225660
Publikováno v:
2008 IEEE Ultrasonics Symposium.
Background and Objective: Augmentation of local drug delivery from targeted nanoparticles (NP) with nondestructive, noncavitational clinical ultrasound (US) offers the potential to enhance therapeutic efficacy in diseases such as cancer while limitin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::887950f44fb9e45cec8d4f3daab07f00
https://doi.org/10.1109/ultsym.2008.0136
https://doi.org/10.1109/ultsym.2008.0136
Publikováno v:
The FASEB Journal. 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0877dc368a64ccc5d0e4ced3226fabf9
https://doi.org/10.1096/fasebj.22.1_supplement.1136.15
https://doi.org/10.1096/fasebj.22.1_supplement.1136.15
Publikováno v:
IEEE Ultrasonics Symposium, 2005..
Perfluorocarbon (PFC) nanoparticles can serve as a very specific site-targeted contrast and therapeutic agent after binding to specific cellular biomarkers. Ultrasound has been used in conjunction with microbubbles to enhance the delivery of drugs an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bac190108069c5ba9601eb9ee40702a
https://doi.org/10.1109/ultsym.2005.1603195
https://doi.org/10.1109/ultsym.2005.1603195